Raleigh, NC, United States of America

Robert Ferone


Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Research Triangle Park, NC (US) (1989)
  • Raleigh, NC (US) (1995 - 2005)

Company Filing History:


Years Active: 1989-2005

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert Ferone

Introduction

Robert Ferone is a notable inventor based in Raleigh, NC, with a significant portfolio of 8 patents. His work primarily focuses on pharmaceutical innovations, particularly in the field of cancer treatment. Ferone's contributions have advanced the understanding and application of benzoquinazoline compounds in medical formulations.

Latest Patents

Among his latest patents, Ferone has developed a combination of benzoquinazoline antifolates and protecting agents. This invention utilizes a protecting agent, such as a folate derivative like folic acid or leucovorin, in conjunction with a non-competitive folic acid analogue, specifically benzoquinazoline derivatives. This combination aims to reduce the side effects associated with administering non-competitive folic acid analogues. Additionally, he has patented pharmaceutically active benzoquinazoline compounds, which are useful in treating tumors. These compounds are characterized by specific chemical formulas and structures that enhance their pharmacological efficacy.

Career Highlights

Ferone has had a distinguished career, working with prominent companies such as SmithKline Beecham Corporation and Burroughs Wellcome Co. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Throughout his career, Ferone has collaborated with notable colleagues, including William Pendergast and Julius Vass Johnson. These partnerships have fostered innovation and have been instrumental in advancing their shared research goals.

Conclusion

Robert Ferone's innovative work in the pharmaceutical field, particularly with benzoquinazoline compounds, showcases his commitment to improving cancer treatment options. His patents reflect a deep understanding of medicinal chemistry and a dedication to enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…